🇮🇳IN
Sign In
VI

VIVOBIOT

NSE

Vivo Bio Tech Ltd

₹12.93

-1.77(-12.04%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

VIVOBIOT financial summary

For Mar 2026, Vivo Bio Tech Ltd reported revenue of ₹53 crore, which grew 12.6% from the previous year. Net profit was -₹2 crore, which fell 125.6% year on year, on an operating margin of 40%. Earnings per share came in at -₹0.87. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹53 crore
Net profit-₹2 crore
Operating margin40%
EPS-₹0.87

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer